Categories: Entertainment

Vantage Wins ‘Best Mobile Trading App – APAC’ at the UF Awards APAC 2025

PORT VILA, Vanuatu, Nov. 25, 2025 /PRNewswire/ — Vantage, the leading multi-asset broker, is delighted to announce it has been awarded Best Mobile Trading App – APAC at the prestigious UF AWARDS APAC 2025, held during the iFX EXPO Asia 2025.

- Advertisement -

Now in its sixth edition, the UF Awards APAC recognise excellence across the Asia-Pacific region, celebrating the finest fintech and online trading brands that deliver outstanding products and services. This recognition was presented to the Vantage brand as part of the event’s regional award categories.

- Advertisement -

The Best Mobile Trading App award honours Vantage’s commitment to delivering a best-in-class mobile experience. With intuitive design, lightning-fast execution, and advanced features built for both new and experienced traders, Vantage’s mobile platform offers the tools and performance needed to trade confidently.

- Advertisement -

Marc Despallieres, CEO of Vantage, stated: “We are honoured to receive this recognition from the industry. Winning Best Mobile Trading App in the APAC region underscores our dedication to developing technology that empowers traders. We will continue to innovate and deliver mobile solutions that make trading smarter and more accessible.”

- Advertisement -

This accolade adds to Vantage’s growing list of international honours and reinforces the brand’s position as a leading mobile-first trading platform.

- Advertisement -

For more information about Vantage’s mobile trading app and award-winning services, visit the Vantage website. Service availability varies by jurisdiction and entity.

- Advertisement -

About Vantage

- Advertisement -

Vantage Markets (or Vantage) is a multi-asset CFD broker offering clients access to a nimble and powerful service for trading Contracts for Difference (CFDs) products, including Forex, Commodities, Indices, Shares, ETFs, and Bonds.

- Advertisement -

With 16 years of market experience, Vantage goes beyond the role of broker, providing a reliable trading platform that provides clients access to trading opportunities.

- Advertisement -

trade smarter @vantage

- Advertisement -

RISK WARNING: CFDs are complex instruments and carry a high risk of losing money rapidly due to leverage. Ensure you understand the risks before trading.

- Advertisement -

Disclaimer: This article is provided for informational purposes only and does not constitute financial advice, an offer, or solicitation of any financial products or services. The content is not intended for residents of any jurisdiction where such distribution or use would be contrary to local law or regulation. The awards described are brand-level recognitions and do not indicate the licensing permissions of any specific Vantage entity. Readers are advised to seek independent professional advice before making any investment or financial decisions. Any reliance you place on the information presented is strictly at your own risk.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2831521/Vantage_Wins__Best_Mobile_Trading_App___APAC__UF_Awards.jpg 
Logo – https://mma.prnewswire.com/media/1745281/Vantage_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/vantage-wins-best-mobile-trading-app–apac-at-the-uf-awards-apac-2025-302625200.html

- Advertisement -
PRNW Agency

Recent Posts

Sri Adhikari Brothers Television Network Ltd. (SABTNL) Charts New Technology-Led Future with Strategic Transformation and 50 MW AI & Green Data Centre Proposal

Sri Adhikari Brothers Television Network Ltd. (SABTNL) (BSE 530943) (NSE: SABTNL) (ISIN: INE416A01044), today announced…

1 hour ago

FITUR 2026 Expands Its Travel Technology Area by 50%, Strengthening Its Role as the Leading Hub for Innovation-Tourism Dialogue

Located in the new Knowledge Hub (Hall 12), this area brings together startups and firms…

2 hours ago

Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS

Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids…

6 hours ago

Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over…

6 hours ago

GigaDevice Launches GD25NX Series xSPI NOR Flash with Dual-Voltage Design

BEIJING--(BUSINESS WIRE)--#Automotive--GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and…

6 hours ago

Friendly Fraud Expected to Increase by 25% Between Thanksgiving and Cyber Monday, Warns ACI Worldwide

ACI’s Payments Intelligence approach offers merchants complete journey protection—stopping friendly fraud and chargeback abuse in…

6 hours ago